Large expert-curated database for benchmarking document similarity detection in biomedical literature search
Brown P. et al, (2019), DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION
Corrigendum to "A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening" [Maturitas 109 (2018) 81-88].
Koleva-Kolarova RG. et al, (2018), Maturitas, 114
Molecular imaging with positron emission tomography and computed tomography (PET/CT) for selecting first-line targeted treatment in metastatic breast cancer: A cost-effectiveness study
Koleva-Kolarova RG. et al, (2018), Oncotarget, 9, 19836 - 19846
A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening
Koleva-Kolarova RG. et al, (2018), EUROPEAN JOURNAL OF CANCER, 92, S11 - S12
A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening.
Koleva-Kolarova RG. et al, (2018), Maturitas, 109, 81 - 88
Increased life expectancy as a result of non-hormonal targeted therapies for HER2 or hormone receptor positive metastatic breast cancer: A systematic review and meta-analysis.
Koleva-Kolarova RG. et al, (2017), Cancer Treat Rev, 55, 16 - 25
Correspondence - Reply to THEBREAST-D-15-702.
Koleva-Kolarova RG. et al, (2016), Breast, 27, 184 - 185
To screen or not to screen for breast cancer? How do modelling studies answer the question?
Koleva-Kolarova RG. et al, (2015), Curr Oncol, 22, e380 - e382
Simulation models in population breast cancer screening: A systematic review.
Koleva-Kolarova RG. et al, (2015), Breast, 24, 354 - 363
The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients.
Koleva-Kolarova RG. et al, (2015), Br J Cancer, 112, 1617 - 1625
Appraising the hospital reform in Bulgaria 2000-10-lessons learned and future perspectives
Koleva-Kolarova R. et al, (2010), EUROPEAN JOURNAL OF PUBLIC HEALTH, 20, 271 - 271
Necessity of reform in Bulgarian pharmaceutical reimbursement system-prognostic results
Vekov T. et al, (2010), EUROPEAN JOURNAL OF PUBLIC HEALTH, 20, 192 - 193